Cell Reports (Jul 2015)
Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial Integrity
- Fei Yao,
- Jaya P. Kausalya,
- Yee Yen Sia,
- Audrey S.M. Teo,
- Wah Heng Lee,
- Alicia G.M. Ong,
- Zhenshui Zhang,
- Joanna H.J. Tan,
- Guoliang Li,
- Denis Bertrand,
- Xingliang Liu,
- Huay Mei Poh,
- Peiyong Guan,
- Feng Zhu,
- Thushangi Nadeera Pathiraja,
- Pramila N. Ariyaratne,
- Jaideepraj Rao,
- Xing Yi Woo,
- Shaojiang Cai,
- Fabianus H. Mulawadi,
- Wan Ting Poh,
- Lavanya Veeravalli,
- Chee Seng Chan,
- Seong Soo Lim,
- See Ting Leong,
- Say Chuan Neo,
- Poh Sum D. Choi,
- Elaine G.Y. Chew,
- Niranjan Nagarajan,
- Pierre-Étienne Jacques,
- Jimmy B.Y. So,
- Xiaoan Ruan,
- Khay Guan Yeoh,
- Patrick Tan,
- Wing-Kin Sung,
- Walter Hunziker,
- Yijun Ruan,
- Axel M. Hillmer
Affiliations
- Fei Yao
- Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore 138672, Singapore
- Jaya P. Kausalya
- Epithelial Cell Biology Laboratory, Institute of Molecular and Cell Biology, Singapore 138673, Singapore
- Yee Yen Sia
- Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore 138672, Singapore
- Audrey S.M. Teo
- Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore 138672, Singapore
- Wah Heng Lee
- Computational and Systems Biology, Genome Institute of Singapore, Singapore 138672, Singapore
- Alicia G.M. Ong
- Epithelial Cell Biology Laboratory, Institute of Molecular and Cell Biology, Singapore 138673, Singapore
- Zhenshui Zhang
- Human Genetics, Genome Institute of Singapore, Singapore 138672, Singapore
- Joanna H.J. Tan
- Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore 138672, Singapore
- Guoliang Li
- National Key Laboratory of Crop Genetic Improvement, Center for Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan 430070, China
- Denis Bertrand
- Computational and Systems Biology, Genome Institute of Singapore, Singapore 138672, Singapore
- Xingliang Liu
- Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore 138672, Singapore
- Huay Mei Poh
- Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore 138672, Singapore
- Peiyong Guan
- Computational and Systems Biology, Genome Institute of Singapore, Singapore 138672, Singapore
- Feng Zhu
- The Singapore Gastric Cancer Consortium, National University of Singapore, Singapore 119228, Singapore
- Thushangi Nadeera Pathiraja
- Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore 138672, Singapore
- Pramila N. Ariyaratne
- Computational and Systems Biology, Genome Institute of Singapore, Singapore 138672, Singapore
- Jaideepraj Rao
- Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433, Singapore
- Xing Yi Woo
- Personal Genomic Solutions, Genome Institute of Singapore, Singapore 138672, Singapore
- Shaojiang Cai
- Computational and Systems Biology, Genome Institute of Singapore, Singapore 138672, Singapore
- Fabianus H. Mulawadi
- Computational and Systems Biology, Genome Institute of Singapore, Singapore 138672, Singapore
- Wan Ting Poh
- Personal Genomic Solutions, Genome Institute of Singapore, Singapore 138672, Singapore
- Lavanya Veeravalli
- Research Computing, Genome Institute of Singapore, Singapore 138672, Singapore
- Chee Seng Chan
- Research Computing, Genome Institute of Singapore, Singapore 138672, Singapore
- Seong Soo Lim
- Human Genetics, Genome Institute of Singapore, Singapore 138672, Singapore
- See Ting Leong
- Genome Technology and Biology, Genome Institute of Singapore, Singapore 138672, Singapore
- Say Chuan Neo
- Genome Technology and Biology, Genome Institute of Singapore, Singapore 138672, Singapore
- Poh Sum D. Choi
- Genome Technology and Biology, Genome Institute of Singapore, Singapore 138672, Singapore
- Elaine G.Y. Chew
- Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore 138672, Singapore
- Niranjan Nagarajan
- Computational and Systems Biology, Genome Institute of Singapore, Singapore 138672, Singapore
- Pierre-Étienne Jacques
- Département de Biologie, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada
- Jimmy B.Y. So
- The Singapore Gastric Cancer Consortium, National University of Singapore, Singapore 119228, Singapore
- Xiaoan Ruan
- Personal Genomic Solutions, Genome Institute of Singapore, Singapore 138672, Singapore
- Khay Guan Yeoh
- The Singapore Gastric Cancer Consortium, National University of Singapore, Singapore 119228, Singapore
- Patrick Tan
- Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore 138672, Singapore
- Wing-Kin Sung
- Computational and Systems Biology, Genome Institute of Singapore, Singapore 138672, Singapore
- Walter Hunziker
- Epithelial Cell Biology Laboratory, Institute of Molecular and Cell Biology, Singapore 138673, Singapore
- Yijun Ruan
- The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA
- Axel M. Hillmer
- Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore 138672, Singapore
- DOI
- https://doi.org/10.1016/j.celrep.2015.06.020
- Journal volume & issue
-
Vol. 12,
no. 2
pp. 272 – 285
Abstract
Genome rearrangements, a hallmark of cancer, can result in gene fusions with oncogenic properties. Using DNA paired-end-tag (DNA-PET) whole-genome sequencing, we analyzed 15 gastric cancers (GCs) from Southeast Asians. Rearrangements were enriched in open chromatin and shaped by chromatin structure. We identified seven rearrangement hot spots and 136 gene fusions. In three out of 100 GC cases, we found recurrent fusions between CLDN18, a tight junction gene, and ARHGAP26, a gene encoding a RHOA inhibitor. Epithelial cell lines expressing CLDN18-ARHGAP26 displayed a dramatic loss of epithelial phenotype and long protrusions indicative of epithelial-mesenchymal transition (EMT). Fusion-positive cell lines showed impaired barrier properties, reduced cell-cell and cell-extracellular matrix adhesion, retarded wound healing, and inhibition of RHOA. Gain of invasion was seen in cancer cell lines expressing the fusion. Thus, CLDN18-ARHGAP26 mediates epithelial disintegration, possibly leading to stomach H+ leakage, and the fusion might contribute to invasiveness once a cell is transformed.